Thomas Poiret

892 total citations
30 papers, 656 citations indexed

About

Thomas Poiret is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Thomas Poiret has authored 30 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Thomas Poiret's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (7 papers). Thomas Poiret is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (7 papers). Thomas Poiret collaborates with scholars based in Sweden, Canada and United States. Thomas Poiret's co-authors include Markus Maeurer, Lalit Rane, Ernest Dodoo, Isabelle Magalhaes, Alimuddin Zumla, Qingda Meng, Martin Rao, Zhenjiang Liu, Esther Schoutrop and Davide Valentini and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Thomas Poiret

27 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Poiret Sweden 14 327 312 129 126 113 30 656
Luciano Castiello United States 17 302 0.9× 425 1.4× 82 0.6× 68 0.5× 270 2.4× 30 842
Shinichi Esaki Japan 13 357 1.1× 184 0.6× 69 0.5× 117 0.9× 99 0.9× 27 660
Cecilia Barese United States 13 383 1.2× 381 1.2× 56 0.4× 81 0.6× 178 1.6× 25 674
Katherine Matthews Australia 13 300 0.9× 346 1.1× 46 0.4× 133 1.1× 114 1.0× 17 656
Sweera Rehan Australia 12 318 1.0× 248 0.8× 77 0.6× 223 1.8× 77 0.7× 16 584
Cindy Lin United States 10 232 0.7× 595 1.9× 167 1.3× 131 1.0× 339 3.0× 18 934
Miriam Kim United States 14 290 0.9× 139 0.4× 61 0.5× 47 0.4× 140 1.2× 47 570
Dobrin Draganov United States 10 187 0.6× 238 0.8× 39 0.3× 40 0.3× 243 2.2× 16 569
Juho J. Miettinen Finland 10 166 0.5× 244 0.8× 80 0.6× 150 1.2× 479 4.2× 26 790
Nobuhiko Imahashi Japan 14 306 0.9× 283 0.9× 45 0.3× 31 0.2× 111 1.0× 41 622

Countries citing papers authored by Thomas Poiret

Since Specialization
Citations

This map shows the geographic impact of Thomas Poiret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Poiret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Poiret more than expected).

Fields of papers citing papers by Thomas Poiret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Poiret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Poiret. The network helps show where Thomas Poiret may publish in the future.

Co-authorship network of co-authors of Thomas Poiret

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Poiret. A scholar is included among the top collaborators of Thomas Poiret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Poiret. Thomas Poiret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poiret, Thomas, Mahdi Mohammadpour, Johan Henriksson, et al.. (2025). Production of functional CD19 CAR T cells under hypoxic manufacturing conditions. Frontiers in Immunology. 16. 1675786–1675786.
2.
3.
Poiret, Thomas, et al.. (2024). CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude. Journal of Translational Medicine. 22(1). 273–273. 5 indexed citations
4.
Hansen, Thomas B., et al.. (2024). Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy. Journal of Translational Medicine. 22(1). 250–250. 4 indexed citations
5.
Schoutrop, Esther, Ibrahim El‐Serafi, Thomas Poiret, et al.. (2021). Mesothelin-Specific CAR T Cells Target Ovarian Cancer. Cancer Research. 81(11). 3022–3035. 76 indexed citations
6.
7.
Liu, Zhenjiang, Thomas Poiret, Qingda Meng, et al.. (2018). Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer. Journal of Translational Medicine. 16(1). 182–182. 8 indexed citations
8.
Liu, Zhenjiang, Martin Rao, Thomas Poiret, et al.. (2017). Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma. Oncotarget. 8(46). 80208–80222. 6 indexed citations
9.
Liu, Zhenjiang, Martin Rao, Xiaohua Luo, et al.. (2017). Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 23. 20–24. 13 indexed citations
10.
Liu, Zhenjiang, Thomas Poiret, Oscar Persson, et al.. (2017). NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology Immunotherapy. 67(2). 237–246. 12 indexed citations
11.
Erkers, Tom, Laia Gorchs, Thomas Poiret, et al.. (2017). Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 8. 1861–1861. 21 indexed citations
12.
Meng, Qingda, Zhenjiang Liu, Elena Rangelova, et al.. (2016). Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. Journal of Immunotherapy. 39(2). 81–89. 67 indexed citations
13.
Ambati, Aditya, Sigrun Einarsdottir, Isabelle Magalhaes, et al.. (2015). Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transplant Infectious Disease. 17(3). 371–379. 16 indexed citations
14.
Ambati, Aditya, Thomas Poiret, B.‐M. Svahn, et al.. (2015). Increased β‐haemolytic group A streptococcal M6 serotype and streptodornase B‐specific cellular immune responses in Swedish narcolepsy cases. Journal of Internal Medicine. 278(3). 264–276. 23 indexed citations
15.
Parida, Shreemanta K., Thomas Poiret, Zhenjiang Liu, et al.. (2015). T-Cell Therapy: Options for Infectious Diseases: Table 1.. Clinical Infectious Diseases. 61(suppl 3). S217–S224. 40 indexed citations
16.
Liu, Zhenjiang, Qingda Meng, Markus Maeurer, et al.. (2015). IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P31–P31. 1 indexed citations
17.
Rao, Martin, Davide Valentini, Thomas Poiret, et al.. (2015). B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis. Clinical Infectious Diseases. 61(suppl 3). S225–S234. 58 indexed citations
18.
Valentini, Davide, Simani Gaseitsiwe, Mike Schutkowski, et al.. (2014). Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status. PLoS ONE. 9(4). e89648–e89648. 14 indexed citations
19.
Skrahin, Aliaksandr, Raija Ahmed, Giovanni Ferrara, et al.. (2014). Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. The Lancet Respiratory Medicine. 2(2). 108–122. 95 indexed citations
20.
Poiret, Thomas, Lalit Rane, Mats Remberger, et al.. (2014). Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults. BMC Immunology. 15(1). 25–25. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Castiello Breakdown of academic impact, for papers by Shinichi Esaki Breakdown of academic impact, for papers by Cecilia Barese Breakdown of academic impact, for papers by Katherine Matthews Breakdown of academic impact, for papers by Sweera Rehan Breakdown of academic impact, for papers by Cindy Lin Breakdown of academic impact, for papers by Miriam Kim Breakdown of academic impact, for papers by Dobrin Draganov Breakdown of academic impact, for papers by Juho J. Miettinen Breakdown of academic impact, for papers by Nobuhiko Imahashi
Rankless by CCL
2026